Physician

Siddhartha Annamraju Rao, M.D.

According to 2025 Medicare claims, Siddhartha Rao, M.D. (NPI: 1578644977) practices interventional cardiology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RAO CLINIC PLLC (NPI: 1073148581; TIN: 84-4464066) and primary practice location at 27518-8116.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 508 traditional Medicare patients, billed 11,954 HCPCS/CPT codes, and received $1,474,001 in Medicare payments. The top billing code was 93923 (Complete ultrasound study of arm and leg arteries). Part D data shows 921 prescription claims across 360 beneficiaries totaling $59,676 in drug costs, led by Xarelto (Rivaroxaban). 2017 DME data shows 25 claims. Open Payments data shows 69 records totaling $74,527. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $234,522 to $1,474,001. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $108,834 and ending at $59,676. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,105	2,771	$234,522
2016	1,440	3,812	$310,296
2017	984	3,072	$293,194
2018	1,039	3,161	$325,853
2019	932	2,806	$297,687
2020	438	4,832	$647,957
2021	412	13,654	$1,820,827
2022	580	15,443	$2,444,555
2023	423	9,228	$1,172,885
2024	508	11,954	$1,474,001

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	185	1,449	$108,834
2016	211	1,532	$130,054
2017	227	1,340	$149,671
2018	257	1,493	$151,568
2019	273	1,586	$180,851
2020	238	1,189	$139,487
2021	224	733	$92,696
2022	283	982	$134,867
2023	239	801	$110,805
2024	360	921	$59,676

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$26,845
2016	N/R	48	$3,037
2017	N/R	25	$1,159
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93923	Complete ultrasound study of arm and leg arteries	153	185	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	206	278	$66
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	134	166	$37
76937	Ultrasonic guidance for blood vessel access	144	177	$28
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	128	7,741	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	61	2,662	$47,824
Clopidogrel	Clopidogrel Bisulfate	308	22,390	$3,228
Atorvastatin Calcium	Atorvastatin Calcium	142	10,280	$1,247
Methylprednisolone	Methylprednisolone	219	1,128	$1,232
Celecoxib	Celecoxib	118	3,204	$1,143

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$46,142	Philips North America LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	17	$28,386	Abbott Laboratories
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Siddhartha Annamraju Rao, M.D.?

Tedicare shows public-source Medicare data for Siddhartha Annamraju Rao, M.D. (NPI 1578644977), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Siddhartha Annamraju Rao, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Siddhartha Annamraju Rao, M.D.?

Siddhartha Annamraju Rao, M.D. is linked to RAO CLINIC PLLC (billing NPI 1073148581) in the available physician profile data.

Does Siddhartha Annamraju Rao, M.D. have Open Payments data?

Siddhartha Annamraju Rao, M.D. has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.